Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-06

FDA Approved: ZOLMITRIPTAN — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for Zolmitriptan from Alembic Pharmaceuticals Limited, indicating an updated or additional approval for this generic pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolmitriptan (zolmitriptan)

Snippet

SUPPL AP for ZOLMITRIPTAN (ZOLMITRIPTAN)